EMD-22730

Single-particle
3.4 Å
EMD-22730
3D View Gallery
Deposition: 27/09/2020
Map released: 21/10/2020
Last modified: 20/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-22730

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-7k8t summary report (pdf.gz) Map-7k8t FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C002 (State 2)

EMD-22730

Single-particle
3.4 Å
EMD-22730
3D View Gallery
Deposition: 27/09/2020
Map released: 21/10/2020
Last modified: 20/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2
Sample: Ternary complex of SARS-CoV-2 S 2P glycoprotein with Fab fragments of the human neutralizing antibody C002
Fitted models: 7k8t

Deposition Authors: Malyutin AG , Barnes CO , Bjorkman PJ
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies.
Barnes CO , Jette CA, Abernathy ME, Dam KA , Esswein SR , Gristick HB, Malyutin AG , Sharaf NG , Huey-Tubman KE, Lee YE, Robbiani DF , Nussenzweig MC, West Jr AP, Bjorkman PJ
(2020) Nature , 588 , 682 - 687
PUBMED: 33045718
DOI: doi:10.1038/s41586-020-2852-1
ISSN: 1476-4687
ASTM: NATUAS